Results 131 to 140 of about 1,516,429 (359)

Intracameral Injection of Bevacizumab for the Treatment of Neovascular Glaucoma [PDF]

open access: yes, 2011
Purpose: To assess the duration of the effect of intracameral bevacizumab in patients presenting with rubeosis iridis and neovascular glaucoma (NVG). Methods: Retrospective analysis of 24 consecutive eyes of 24 patients with decompensated NVG (> 21 mm Hg)
Haritoglou, Christos   +3 more
core   +1 more source

<p>A Comparison of Conventional Intravitreal Injection Method vs InVitria Intravitreal Injection Method</p>

open access: yesClinical Ophthalmology, 2020
To compare use of the conventional intravitreal injection method to the InVitria intravitreal injection device. Three outcome measures were studied: patient comfort, speed of injection and cost-effectiveness.A prospective review of 58 patients was undertaken.
Michelle Blyth   +3 more
openaire   +6 more sources

Bilateral occlusive retinal vasculitis secondary to intravitreal faricimab injection: a case report and review of literature

open access: yesEye and Vision
Background This article describes a rare occurrence of bilateral retinal occlusive vasculitis secondary to intravitreal faricimab injection. Case presentation A 72-year-old female with age-related macular degeneration presented with bilateral retinal ...
Yong Min Lee   +4 more
doaj   +1 more source

Molecular and cellular mechanisms underlying gyrate atrophy: Why is the retina primarily affected?

open access: yesActa Ophthalmologica, EarlyView.
Abstract Gyrate atrophy of the choroid and retina (GACR; OMIM #258870) is a rare early‐onset autosomal recessive disorder, caused by bi‐allelic pathogenic variants in the gene coding for ornithine aminotransferase (OAT) resulting in hyperornithinaemia.
Mark J. N. Buijs   +12 more
wiley   +1 more source

Intravitreal injections: A review of pharmacological agents and techniques

open access: yes, 2016
Over the past three decades, intravitreal delivery of pharmacotherapeutic agents has advanced tremendously with many drugs being developed solely for intravitreal use.
Hasanain Shikari, Preetam M Samant
semanticscholar   +1 more source

Silicone oil droplets following intravitreal bevacizumab injections

open access: yesAmerican Journal of Ophthalmology Case Reports, 2018
Purpose: To report the transient resurgence of symptomatic silicone oil droplets following intravitreal bevacizumab injections. Observations: We report seven patients presenting with silicone oil droplets following intravitreal bevacizumab injections ...
Jea H. Yu   +5 more
doaj  

Experiences of using Aflibercept in diabetic macular edema treatment: data from routine clinical practice

open access: yesРоссийский офтальмологический журнал, 2018
Purpose. To assess the effectiveness and safety of intravitreal aflibercept injections in clinically significant diabetic macular edema (DME) in a routine clinical practice.Material and methods. This was a prospective, observational, single-center study. 
E. Yu. Santoro
doaj   +1 more source

Aqueous humour concentrations of HB‐EGF, EGF and VEGF‐A and axial length in humans

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To investigate relationships between the intraocular concentrations of heparin‐binding epidermal growth factor (HB‐EGF), epidermal growth factor (EGF) and vascular endothelial growth factor A (VEGF‐A) in dependence on axial length in humans. Design Clinical interventional cohort study.
Wen‐Da Zhou   +8 more
wiley   +1 more source

Corticosteroid implants for chronic non-infectious uveitis. [PDF]

open access: yes, 2016
BACKGROUND: Uveitis is a term used to describe a heterogeneous group of intraocular inflammatory diseases of the anterior, intermediate, and posterior uveal tract (iris, ciliary body, choroid).
Brady, Christopher J   +7 more
core   +2 more sources

Comparative efficacy of intravitreal anti‐VEGF therapy for neovascular age‐related macular degeneration: A systematic review with network meta‐analysis

open access: yesActa Ophthalmologica, EarlyView.
Abstract The aim of this review was to evaluate the comparative efficacy of intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) therapy for neovascular AMD. We searched 12 literature databases for randomised clinical trials (RCT) on anti‐VEGF therapy for neovascular AMD and extracted data on: change from baseline to 12 months in best ...
Emilie T. S. Butler   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy